glycolaldehyde has been researched along with Alzheimer Disease in 1 studies
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choei, H | 1 |
| Sasaki, N | 1 |
| Takeuchi, M | 1 |
| Yoshida, T | 1 |
| Ukai, W | 1 |
| Yamagishi, S | 1 |
| Kikuchi, S | 1 |
| Saito, T | 1 |
1 other study available for glycolaldehyde and Alzheimer Disease
| Article | Year |
|---|---|
Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
Topics: Acetaldehyde; Aged; Alzheimer Disease; Brain; Glycation End Products, Advanced; Glyceraldehyde; Huma | 2004 |